Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in BCYC — Bicycle Therapeutics PLC

CIK 886982 NEW YORK, NY
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$514,231
+$3,149 QoQ
Shares Held
121,281
+10.1% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 103 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. BCYC ranks #285 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in BCYC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $514,231 121,281
2026-03-31 $511,082 110,147
2025-12-31 $175,102 24,732
2025-06-30 $363,241 52,265
2025-03-31 $213,880 25,192
2024-06-30 $281,477 13,907
2024-03-31 $1,380,705 55,450
2023-06-30 $464,846 18,215
2023-03-31 $224,355 10,548
2022-12-31 $2,384,368 80,553
2022-09-30 $2,449,068 105,291
2022-06-30 $2,589,590 154,326
2022-03-31 $7,164,068 163,265
2021-12-31 $1,259,217 20,687
2021-09-30 $618,152 14,863